Biofrontera AG BFRA
Set alert
As of Apr 24, 3:47 PM ET
52-week range unavailable
- Open
- 3.10
- Prev close
- 2.67
- Mkt cap
- 75.72M
- Vol
- 4.95K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.60
- High
- 3.10
- Forward P/E
- -3.47
- Beta
- 1.55
- Short ratio
- 0.79
- Inst. own
- 3.00%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Apr 11, 2022
- 50-d avg
- 2.89
- 200-d avg
- 4.65
- 1y target
- 8.50
News
5 months ago globenewswire.com
Biofrontera Inc. Reports First Quarter 2026 Financial Results and Provides a Business Update
Woburn, MA, May 14, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ: BFRI) (the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy…
5 months ago globenewswire.com
Biofrontera Inc. to Report First Quarter 2026 Financial Results and Host a Conference Call on May 14, 2026
WOBURN, Mass., May 08, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of…
2 years ago investorplace.com
Why Is Biofrontera (BFRI) Stock Down Today?
Biofrontera (NASDAQ: BFRI ) stock is on the move Friday alongside heavy trading of the biopharmaceutical company's shares. This has more than 4.3 million shares of BFRI stock changing hands as of…
3 years ago investorplace.com
BFRI Stock Earnings: Biofrontera Misses EPS, Revenue Estimates
Biofrontera (NASDAQ: BFRI ) reported results for the first quarter of 2023. Biofrontera posted a loss per share of 28 cents.
4 years ago seekingalpha.com
Biofrontera AG (BFAGY) Management on Q1 2022 Results - Earnings Call Transcript
Biofrontera AG (OTC:BFAGY) Q1 2022 Earnings Conference Call May 19, 2022 8:00 AM ET Company Participants Anke zur Mühlen - Corporate Communications & Investor Relations Ludwig Lutter - Chief…
4 years ago benzinga.com
Why Biofrontera Stock Is Surging Today
Biofrontera Inc (NASDAQ: BFRI) shares are trading significantly higher Wednesday after the company announced it received U.S. Food and Drug Administration approval for its cGMP laboratory in Germany.…
4 years ago seekingalpha.com
Biofrontera Inc. (BFRI) CEO Erica Monaco on Q4 2021 Results - Earnings Call Transcript
Biofrontera Inc. (BFRI) CEO Erica Monaco on Q4 2021 Results - Earnings Call Transcript
4 years ago benzinga.com
5 Short Squeeze Candidates To Watch: Vinco Ventures, TSR, Biofrontera And More
Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value instead of falling.
4 years ago benzinga.com
Why Are Biofrontera Shares Rising Today?
Biofrontera Inc BFRI has provided an update on the patient recruitment for the Phase 3 study for superficial basal cell carcinoma (sBCC) with Ameluz photodynamic therapy (PDT) combined with…
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 88 companies set new 52-week lows.
4 years ago seekingalpha.com
Is Biofrontera Stock A Buy Or Sell? Several Catalysts In 2022
Biofrontera is eyeing significant growth opportunities for its FDA-approved skin disease photodynamic therapy drug "Ameluz". Updates regarding several ongoing clinical studies for expanded label…
4 years ago benzinga.com
What's Going On With Biofrontera Shares Today?
Biofrontera Inc (NASDAQ:BFRI) is trading higher Tuesday on abnormally-high volume. The stock is seeing increased interest across social media platforms.
4 years ago pulse2.com
Biofrontera Stock (BFRI): Why The Price Surged Today
The stock price of Biofrontera Inc (NASDAQ: BFRI) increased by over 40% during intraday trading today. This is why it happened.
4 years ago investorplace.com
BFRI Stock Alert: The Social Media Chatter That Has Biofrontera Booming Today
Biofrontera (BFRI) stock is on the move today as traders take to Twitter (TWTR) to discuss the latest news surrounding the company. The post BFRI Stock Alert: The Social Media Chatter That Has…
4 years ago benzinga.com
Biofrontera Shares Are Trading Higher After Benchmark Initiates Coverage
Benchmark initiated coverage of Biofrontera Inc (NASDAQ:BFRI) with a Buy rating and $11 price target. The Company specializes in medical dermatology, which recently came public in the U.S. as a…
4 years ago investorplace.com
Biofrontera Is Promising, But Could Be Limited by Competition and Volatility
BFRI stock could rise on the company's treatment for actinic keratosis, which can lead to skin cancer, but it has hurdles to overcome first. The post Biofrontera Is Promising, But Could Be Limited by…
4 years ago investorplace.com
$20 Price Prediction Is Ambitious but Possible for Biofrontera
BFRI stock is an imperfect investment as Biofrontera isn't currently profitable, but a new patent could provide a significant revenue source. The post $20 Price Prediction Is Ambitious but Possible…
4 years ago pulse2.com
Biofrontera (BFRI) Stock: Why The Price Surged Today
The stock price of Biofrontera Inc (NASDAQ: BFRI) increased by over 27% during intraday trading today. This is why it happened.
4 years ago benzinga.com
Why Are Biofrontera Shares Surging Today?
The United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Biofrontera Inc (NASDAQ: BFRI) titled "Illumination for Photodynamic Therapy." The patent covers…
4 years ago investorplace.com
BFRI Stock: The News That Has Biofrontera Shares Bounding Higher Today
Biofrontera (BFRI) stock is getting a boost on Thursday thanks to an update from the United States Patent and Trademark Office. The post BFRI Stock: The News That Has Biofrontera Shares Bounding…
4 years ago seekingalpha.com
Biofrontera's (BFRI) CEO Erica Monaco on Q3 2021 Results - Earnings Call Transcript
Biofrontera's (BFRI) CEO Erica Monaco on Q3 2021 Results - Earnings Call Transcript
-
6 years ago benzinga.com
56 Biggest Movers From Friday
Gainers Nano-X Imaging Ltd. (NASDAQ: NNOX) shares gained 32.9% to close at $64.19. Nano X Imaging recently announced it has signed an agreement with SPI Medical for the deployment of 630 Nanox.ARC…
-
6 years ago benzinga.com
76 Biggest Movers From Yesterday
Gainers LMP Automotive Holdings, Inc. (NASDAQ: LMPX) shares surged 69.7% to close at $11.81 on Monday following Q2 results. The company’s earnings came in at $0.02 per share, while revenue jumped 44%…
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Thursday